Bayer's (BAYRY) Chronic Cough Candidate Meets Efficacy Goal

Published on September 7, 2021

Bayer (BAYRY) posts positive data from the phase IIb PAGANINI study which is evaluating its investigational candidate, eliapixant, in patients with re...

Continue reading on website
Other news

Argo Group (ARGO) Gains 46% in a Year: More Room for Upside?

September 7, 2021
Highly profitable business, growth initiatives, an expense initiative program, digitalization and a solid capital position continue to drive Argo Grou...

ETF Strategies to Profit From a Historically Weak September

September 7, 2021
Wall Street has entered into a historically weak month. Investors seeking to remain invested in the equity world should consider some strategies to ov...